- Global Pharma News & Resources

ViewRay® to Present at the 2018 Cantor Global Healthcare Conference

ViewRay® to Present at the 2018 Cantor Global Healthcare Conference

PR Newswire

CLEVELAND, Sept. 25, 2018

CLEVELAND, Sept. 25, 2018 /PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) announced today that members of the executive management team are scheduled to present at the Cantor Global Healthcare Conference in New York, NY.

Event: 2018 Cantor Global Healthcare Conference
Date: Tuesday, October 2, 2018
Time: 2:15pm ET

An audio webcast of the Company's presentation will be available on the investor relations section of ViewRay's website at A replay of the webcast will be available for 7 days after the date of the presentation.

About ViewRay
ViewRay®, Inc. (Nasdaq: VRAY), designs, manufactures and markets the MRIdian® radiation therapy system. MRIdian is built upon a proprietary high-definition MR imaging system designed from the ground up to address the unique challenges and clinical workflow for advanced radiation oncology. Unlike MR systems used in diagnostic radiology, MRIdian's high-definition MR was purposely built to deliver high-precision radiation without unnecessary beam distortion, and consequently, help to mitigate skin toxicity and other safety concerns that may otherwise arise when high magnetic fields interact with radiation beams. ViewRay and MRIdian are registered trademarks of ViewRay, Inc.

View original content:

SOURCE ViewRay, Inc.

Editor Details

Last Updated: 25-Sep-2018